Chemcon Speciality Chemicals Ltd

AGM Details

• AGM on 17 September 2026 at 11:30 IST via VC/OAVM.
• Cut-off date for e-voting/attendance: 10 September 2026.

Key Resolutions

• Ordinary: adopt audited financial statements for year ended 31 March 2026 with Directors' and Auditors' reports.
• Ordinary: re-appoint director by rotation.
• Ordinary: ratify Cost Auditors' remuneration for 2026–27.

Director information

• Director to seek re-appointment: Rajesh Gandhi, retiring by rotation.

Overview

• Standalone BRSR for year ended 31 March 2026; main activity: HMDS, CMIC, bromides; 94% turnover.
• Exports account for 41% of turnover across 15 Indian states and 12 countries.
• 11 locations in India: 10 plants and 1 office.
• CSR turnover INR 23,997.89 Lakhs; net worth INR 48,314.02 Lakhs.
• Reporting boundary: Standalone basis.

Key ESG Risks & Opportunities

• Regulatory compliance and climate change cited as material risks with potential negative financial impact.
• Mitigation includes strict compliance, renewable energy transition, water conservation, and increased recycling.
• Opportunities from sustainable product innovations, expanded markets, improved employee engagement, and carbon footprint reduction.

Governance & Policy Highlights

• Board-level sustainability committee oversees ESG decisions.
• Anti-corruption/anti-bribery policy in place; board-approved; disclosure link provided.
• Value chain policies do not extend to partners.
• ISO 9001:2015 and ISO 14001:2015 certifications in place.
• No external assurance on the BRSR.

Social Responsibility & Workforce

• 238 permanent employees and 150 workers; 1 female among permanent; board female representation 8.33%.
• 100% health and safety wellbeing programs; ESI coverage 38.65%; PF and gratuity 100%.
• 100% training coverage for employees and workers; 15 employee trainings; 28 worker trainings.
• Three-tier grievance mechanism; equal opportunity policy under Disability Act with web link.
• Gross wages paid to females 1.40% of total wages in FY25-26.

Environmental Performance

• Total energy 142.95 million MJ; renewable 111.31; non-renewable 31.64; intensity 0.06.
• Groundwater withdrawal 95,876 KL; total water withdrawal 95,876 KL; ZLD with MEE implemented.
• Total waste 15,627 MT; 9,904 MT recycled; 5,036 MT reused; 14,940 MT recovered; 687 MT disposed.
• ISO 9001:2015 and ISO 14001:2015 certifications.
• Air emissions measured; NOx 22.25, SOx 18.50, PM 76.25; assessed by Aryan Ecogreens.

Stakeholder Engagement & Complaints

• Stakeholders identified: employees, investors, government/regulators, suppliers, customers, banks, community.
• Engagement channels: email, notices, website; frequency: ongoing for employees; need-based for others.
• Shareholders complaints: 0 in FY2025-26; grievance mechanisms exist across stakeholder groups.

Other Notable Metrics

• Purchases from related parties 4.85% of total purchases; sales to related parties 1.09% of total sales.
• Concentration: purchases from trading houses 19.92% across 34 houses; top 10 trading houses 94.33%.
• Sales to dealers 16.76% across 45 dealers; top 10 dealers 87.48%.
• 51% inputs sourced sustainably.
• Direct MSME sourcing 0.19%; in-district sourcing 64.23%; rural 82.98%, metropolitan 17.02%.
• No cyber security framework; no data privacy policy documented.

Financial performance

• Revenue from operations rose 15.7% to ₹23,997.89 lakh.
• EBITDA ₹30.2 crore; margin 12.6%.
• PAT ₹2,359.82 lakh; PAT margin 9.87%.
• Basic EPS ₹6.44; prior year ₹6.68.
• Net cash from operating activities ₹41.55 crore.
• Borrowings ₹5,313.68 lakh; debt/equity 0.11.
• DSCR 2.35x; current ratio 4.41x.

Geography and product mix

• India revenue ₹14,795.89 lakh; outside India ₹9,202.00 lakh; total ₹23,997.89 lakh.
• Exports accounted for 41% of turnover.
• Product portfolio includes HMDS, CMIC, Bromobenzene, and inorganic bromides.
• Manufacturing at Manjusar, Vadodara; 10 plants with in-house lab.

Strategic developments

• Slump sale acquisition of Shivam Petrochem Industries completed Oct 2025; lump-sum ₹3,600 lakh.
• Pooling of interest accounting; goodwill ₹41.38 crore recognised in equity.
• Integration activities progressing with regulatory approvals and license transfers.

Capital structure and liquidity

• Issued share capital ₹3,663.07 lakh; 100% dematerialised.
• Interim dividend declared ₹6.50 per equity share for FY2025-26; record date 28 May 2026.
• Short-term and long-term borrowings structure and cash balances reported; cash and bank balances ₹1,038.62 lakh.

Governance and risk management

• Board comprises 12 directors; 6 independent including 1 woman independent.
• Audit Committee (4 members), Nomination & Remuneration, CSR, Risk Management, and Stakeholders Relationship Committees.
• Secretarial Audit with no qualifications; whistle blower policy in place; no shareholder complaints in 2025-26.

CSR and ESG

• CSR obligation ₹88.41 lakh; expenditure ₹88.02 lakh; unspent ₹0.39 lakh to be transferred by 30 Sep 2026.
• CSR policy and programs disclosed on company website.

Audit, controls and compliance

• Statutory auditors Shah Mehta & Bakshi; unmodified opinion.
• Internal financial controls adequate and operating effectively; Secretarial Compliance reports filed.

Outlook and risks

• Global and domestic demand for specialty chemicals remains favorable; India positioned for growth.
• Profitability pressured by elevated input costs and raw material volatility; management focused on cost control and efficiency.

Meeting Details

• Board meeting date: August 3, 2026; time and venue not disclosed.

Key Agenda Items

• Unaudited quarterly results for the quarter ended June 30, 2026 to be considered.
• Directors' Report and annexures for the financial year ended March 31, 2026.
• Notice of the 37th AGM and related matters.

Other Notes

• Trading window closed for designated persons and relatives from July 1, 2026 until 48 hours after results.

Dematerialisation processing and listing

• Securities received for dematerialisation during quarter ended 30 June 2026 were confirmed to depositories.
• Securities dematerialised have been listed on stock exchanges where earlier securities are listed.
• Depository name substituted as registered owner within prescribed timelines; certificates mutilated and cancelled after verification.

Rating Details

• CRISIL reaffirms long-term BBB+/Stable rating for Chemcon's Rs 53-crore bank facilities.
• Rating action communicated via CRISIL credit rating letter dated 7 July 2026.
• Outlook: Stable.
• Rating agency: CRISIL.

Auditor's Review

• Independent auditor reviewed Chemcon's unaudited standalone Q3 and 9M FY26 results.
• Review conducted per SRE 2410 standards, providing moderate assurance, not audit opinion.
• No material misstatements or disclosure issues found in financial results per Ind AS 34.

Financial Results Summary

• Total income for Q3 FY26 was ₹5,732.50 lakh, up from ₹5,439.45 lakh in Q3 FY25.
• Nine months ended Dec 31, 2025, total income was ₹16,455.72 lakh versus ₹15,258.80 lakh prior year.
• Finance costs for 9M FY26 were ₹9,092.25 lakh, up from ₹7,475.33 lakh in 9M FY25.
• Profit before tax for 9M FY26 was ₹2,116.62 lakh, up from ₹1,722.70 lakh in 9M FY25.
• Profit after tax for 9M FY26 was ₹1,707.55 lakh, up from ₹880.81 lakh in 9M FY25.
• Basic EPS for 9M FY26 was ₹4.70 compared to ₹2.40 in 9M FY25.

Other Financial Metrics

• Other equity stood at ₹3,653.07 lakh as of Dec 31, 2025.
• Tax expense for 9M FY26 was ₹593.92 lakh compared to ₹304.20 lakh in 9M FY25.

Business Model

• Chemcon Speciality Chemicals operates in manufacturing specialty chemicals.
• Financial results reported on standalone basis for quarter and nine months ended Dec 31, 2025.